Advertisement
Advertisement
BSX
Boston Scientific Corp.
42.75
USDSponsored
-1.89
-4.23%
Nov 06, 15:59 UTC -5
Closed
After-Market
42.82
+0.07
+0.16%
Boston Scientific Corp. (BSX) Earnings
BSX Earnings Reports
Positive Surprise Ratio
BSX beat 35 of 43 last estimates.
81%
Next Report
Date of Next Report
Feb 02, 2027
Estimate for Q4 26 (Revenue/ EPS)
$5.24B
/$0.78
Implied change from Q3 26 (Revenue/ EPS)
+2.02%
/+6.85%
Implied change from Q4 25 (Revenue/ EPS)
-0.83%
/-2.50%
Boston Scientific Corp. earnings per share and revenue
On Oct 28, 2026, BSX reported earnings of 0.73 USD per share (EPS) for Q3 26, beating the estimate of 0.72 USD, resulting in a 0.93% surprise. Revenue reached 5.14 billion, compared to an expected 5.10 billion, with a 0.82% difference. The market reacted with a -5.84% price change (close before vs. close after earnings).
Looking ahead to Q4 26, -- analysts forecast an EPS of 0.78 USD, with revenue projected to reach 5.24 billion USD, implying an increase of 6.85% EPS, and increase of 2.02% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Insulet Corporation
Report Date
Nov 04, 2026 For Q3 26
Estimate
$1.61
Actual
$1.99
Surprise
+22.95%
BillionToOne, Inc. Class A Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.14
Actual
$0.32
Surprise
+115.34%
ICU Medical Inc
Report Date
Nov 05, 2026 For Q3 26
Estimate
$2.17
Actual
$2.44
Surprise
+11.93%
Envista Holdings Corporation Common stock, $0.01 par value per share
Report Date
Nov 04, 2026 For Q3 26
Estimate
$0.36
Actual
$0.40
Surprise
+10.04%
Prestige Consumer Healthcare Inc.
Report Date
Nov 05, 2026 For Q2 27
Estimate
$1.08
Actual
$1.12
Surprise
+4.28%
Trulieve Cannabis Corp.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.07
Actual
$0.09
Surprise
+26.05%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.05
Actual
-$0.03
Surprise
+48.10%
Apyx Medical Corporation Common Stock
Report Date
Nov 05, 2026 For Q3 26
Estimate
-$0.09
Actual
-$0.04
Surprise
+57.98%
Biote Corp. Class A Common Stock
Report Date
Nov 04, 2026 For Q3 26
Estimate
-$0.02
Actual
$0.01
Surprise
+149.02%
Nephros Inc.
Report Date
Nov 05, 2026 For Q3 26
Estimate
$0.02
Actual
$0.05
Surprise
+110.08%
FAQ
What were Boston Scientific Corp.'s earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Boston Scientific Corp. reported EPS of $0.73, beating estimates by 0.93%, and revenue of $5.14B, 0.82% above expectations.
How did the market react to Boston Scientific Corp.'s Q3 2026 earnings?
The stock price moved down -5.84%, changed from $45.06 before the earnings release to $42.43 the day after.
When is Boston Scientific Corp. expected to report next?
The next earning report is scheduled for Feb 02, 2027.
What are the forecasts for Boston Scientific Corp.'s next earnings report?
Based on --
analysts, Boston Scientific Corp. is expected to report EPS of $0.78 and revenue of $5.24B for Q4 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.